PAG
EW icon

Private Advisor Group’s Edwards Lifesciences EW Stock Holding History

Private Advisor Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-800
Closed -$304 – 2312
2023
Q3 		$304 Buy
+800
New +$64.3K ﹤0.01% 2282

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Private Advisor Group's EW Position: Q2 2026 in Review

Private Advisor Group increased its Edwards Lifesciences (EW) stake by 23% in Q2 2026, buying an estimated $408K and bringing the position to 26,477 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #932.

Private Advisor Group first reported a position in EW in Q2 2014 and has held it in 46 quarters since. The position peaked at $4.81M in Q3 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Private Advisor Group held 26,477 shares of Edwards Lifesciences worth $2.4M as of Q2 2026.
  • Private Advisor Group bought 4,867 Edwards Lifesciences shares in Q2 2026, an estimated $408K.
  • Edwards Lifesciences made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #932 holding.
  • Private Advisor Group first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 46 quarters since.
  • Private Advisor Group's Edwards Lifesciences position peaked at $4.81M in Q3 2021.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.